Author

L. Cusso

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

M. Desco· 2 shared A. Fernandez Trasancos· 1 shared A. Ferrarini· 1 shared A. Hernandez-Lain· 1 shared A. Hidalgo· 1 shared A. Perez-Nunez· 1 shared C. Blanco-Aparicio· 1 shared C. Nör· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

M. Desco

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Broad therapeutic benefit of myosin inhibition in hypertrophic cardiomyopathy

L. Sen Martin, A. Fernandez Trasancos, M. A. Lopez Unzu, D. Pathak, A. Ferrarini, V. Labrador Cantarero, D. Sanchez Ortiz, M. R. Pricolo, N. Vicente, D. Velazquez Carreras, L. Sanchez Garcia, J. A. Nicolas Avila, M. Sanchez Diaz, S. Schlossarek, L. Cusso, , J. Alegre Cebollada

This study shows that myosin inhibition with mavacamten is effective in treating HCM caused by both truncating and missense variants in MYBPC3, despite different pathomechanisms.

bioRxiv · Mar 22, 2024Physiology

A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis

L. Zhu, N. Yebra, D. Retana, L. Miarka, E. Hernandez-Encinas, C. Blanco-Aparicio, S. Martinez, R. Soffietti, L. Bertero, P. Cassoni, T. Weiss, J. Munoz, J. M. Sepulveda, A. Perez-Nunez, A. Hernandez-Lain, , M. Valiente

The paper introduces a drug-screening platform using organotypic cultures to identify effective treatments for brain metastasis, finding a potent HSP90 inhibitor that works against mouse and human metastases.

bioRxiv · Oct 16, 2020 · PreprintCancer Biology